Tag: Valsartan

Home Valsartan
Post

Valsartan

Valsartan (trade name Diovan) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT) angiotensin receptor.

Post

Valsartan Recall Lawyers

Amid concern that certain generic valsartan and valsartan HCTZ pills may have been distributed for years with impurities that increase the risk of cancer, the drug recall lawyers at Saiontz & Kirk, P.A. are reviewing cases for users of the hypertension drug who have been diagnosed with: Liver Cancer Kidney Cancer Lung Cancer Liver Injury...

Post

Valsartan Cancer Risk Legal News and Lawsuit Information

The drug Valsartan (a generic version of Diovan), which is prescribed to treat high blood pressure and prevent heart failure, has been recalled worldwide after it was found to contain N-nitrosodimethylamine (NDMA), a known carcinogen. Valsartan contamination from a Chinese manufacturing plant may date back to 2012, potentially exposing many patients to Valsartan cancer risk,...

Post

Valsartan Recall

Recently, the US Food and Drug Administration recalled certain varieties of the blood pressure medicine “Valsartan.” This medication is also sold as tablets under the brand Actavis. The FDA found that some of these drugs contained an “impurity” that can cause cancer. This impurity is commonly known as N-nitrosodimethylamine, or NDMA. Its carcinogenic properties are...

Post

Valsartan-HCTZ 160/12.5 Tablet Availability

Is this drug still being made? The pharmacist I went to said it was not. Please answer so I can find out if I’ll be able to get a new prescription. Thanks for your help. ## Hello, Patricia! How are you? Do you happen to know what the markings were on the tablet in question?...

Post

Valsartan Recall, Drug Approval for Smallpox

This weekly video program provides our readers with a comprehensive overview of the latest news, product approvals, FDA regulations and more. Looking back on our week is a must not miss for the busy pharmacy professional.Nicole Grassano, hostess: Hello and welcome to the Pharmacy times News network. I’m Nicole Grassano, your host for our Pharmacy…